Minimally Invasive Surgical Instruments Market Size, Share, and Trends 2025 to 2034

Minimally Invasive Surgical Instruments Market Size and Forecast 2025 to 2034

The global minimally invasive surgical instruments market size was estimated at USD 34.50 billion in 2024 and is anticipated to reach around USD 97.96 billion by 2034, expanding at a CAGR of 11% from 2025 to 2034. Factors such as increasing awareness regarding the benefits of minimally invasive surgical procedures, rising R&D expenditure, and a surge in the cases of lifestyle-related and chronic disorders are some of the major factors driving the growth of the global minimally invasive surgical instruments market in the coming years.

Minimally Invasive Surgical Instruments Market Key Takeaways

• North America led the market in 2024 with revenue share of 45%. 
• Asia Pacific is observed to expand rapidly during the forecast period.
• By application, the orthopedic segment accounted for the dominating and fastest-growing segment in 2024.
• By application, the cardiac surgery segment accounted for considerable growth in the global minimally invasive surgical instruments market over the forecast period.
• By device, the handheld instruments segment is expected to hold the dominating share of the minimally invasive surgical instruments market during the forecast period. 
• By device, the electrosurgical devices segment is expected to grow notably.
• By end use, the hospital segment accounted revenue share of around 69% in 2024.
• By end use, the ambulatory surgical centers segment is expected to grow at the fastest rate during the forecast period.

How Artificial Intelligence (AI) integration is impacting the growth of the minimally invasive surgeries?

Over the years, Artificial Intelligence (AI) integration has significantly reshaped the landscape of the medical devices industry. As AI continues to evolve, its role in minimally invasive surgical instruments is likely to expand. Artificial Intelligence (AI) integration assists in designing minimally invasive surgical instruments to perform minimally invasive surgeries. The integration of AI provides real-time data analysis and assists surgeons in avoiding obstacles during surgery as well as warns of potential complications during a minimally invasive procedure. The technological improvements in minimally invasive surgical instruments assist surgeons in increasingly complex procedures. AI also plays a vital role in surgeries by providing support through interpreting digital visual information displayed on monitors. This directly aids surgeons in the intraoperative decision-making process. Therefore, the Artificial Intelligence (AI) integration has led to an increase in the overall efficiency of the minimally invasive surgical instruments market.

U.S. Minimally Invasive Surgical Instruments Market Size and Growth 2025 to 2034

The U.S. minimally invasive surgical instruments market size was evaluated at USD 10.87 billion in 2024 and is predicted to be worth around USD 31.42 billion by 2034, rising at a CAGR of 11.20% from 2025 to 2034.

North America led the market in 2024 with revenue share of 45%. The minimally invasive surgical instruments market in this region is expanding due to the growing prevalence of various kind of disorders. Heart disease is the biggest cause of mortality in the U.S. as per an updated report published by the Centers for Disease Control and Prevention in September 2022. About 18.2 million American adults aged 20 and above have coronary artery disease and approximately 360,900 people died from coronary heart disorder in 2019. In addition, adoption of innovative technologies is also driving the growth of minimally invasive surgical instruments market in North America region.

Asia-Pacific, on the other hand, is expected to develop at the fastest rate during the forecast period. China and Japan dominate the minimally invasive surgical instruments market in Asia-Pacific region. The factors such as rapid urbanization, growing geriatric population, and growing trend of medical tourism are boosting the growth of minimally invasive surgical instruments market in this region. In addition, the increase in healthcare expenditure is paving way for the expansion of Asia-Pacific minimally invasive surgical instruments market.

Market Overview

Minimally invasive surgeries are surgeries that are done using small incisions and a few stitches. During minimally invasive surgery, one or more small incisions are generally made on the patient’s body.  Minimally invasive surgeries cause less pain, reduce the damage to healthy tissue, and enable faster recovery of patients than with traditional surgery. Minimally invasive surgical instruments include a laparoscope which is a thin and tube-like instrument inserted through one opening to guide the surgery. Tiny surgical instruments are inserted through other openings to operate the surgery efficiently. 

Minimally Invasive Surgical Instruments Market Growth Factors

• The rising prevalence of lifestyle-related and chronic disorders is expected to drive the overall market growth during the analysis period. 
• The rising investment in establishing sophisticated infrastructure in developing economies is positively influencing the minimally invasive surgical instruments market’s growth during the forecast period.
• The increasing acceptance of minimally invasive surgical instruments by surgeons around the world. 
• The rise in the number of minimally invasive surgical procedures is expected to accelerate the market’s growth during the forecast period. The MIS procedures are more cost-effective than in-patient and conventional open surgeries.
• The favorable reimbursement policies along with the increasing investment the Government are expected to contribute to the overall expansion of the market in the coming years.

Market Scope

Market Dynamics

Driver

Rising acceptance rate of minimally invasive surgeries over traditional surgeries

The increasing demand for minimally invasive surgeries over traditional surgeries is expected to boost the demand for minimally invasive surgical instruments during the forecast period. Minimally invasive surgery widely known as laparoscopic or keyhole surgery, involves performing surgical procedures through small incisions rather than large open incisions. Minimally invasive surgical instruments are used to treat chronic disorders including urological, gynecological, gastrointestinal, and others. Minimally invasive procedures offer several benefits over conventional open surgeries such as shortened hospital time, reduced trauma, less scar, minimizes the chance of infection, faster recovery times, and fewer post-operative complications. Such factors are driving the growth of the minimally invasive surgical instruments market in the coming years.

Restraint

Shortage of Skilled Professionals

The shortage of skilled professionals is anticipated to hamper the growth of the market. Several middle- and lower-income countries lack suitable healthcare infrastructure and experienced healthcare professionals to perform minimally invasive surgeries, impacts the overall growth of the market. In addition, high cost associated with technological advanced instrument manufacturing may restrict the expansion of the global minimally invasive surgical instruments market during the forecast period. 

Opportunity

Rapid Technological innovations

The rapid technological innovations are projected to offer lucrative growth opportunities to the minimally invasive surgical instruments market. Several market players in the market are continuously focusing on developing technological surgical instruments including the development of miniaturized devices, advanced imaging technologies, and robotic-assisted systems. In addition, the rise in the adoption of marketing strategies by prominent market players such as new product launches, mergers, collaborations, and acquisitions to gain a competitive edge in the global minimally invasive surgical instruments market in the coming years. For instance, In September 2024, Arthrex, a global leader in minimally invasive surgical technology and medical education, announced the release of OrthoPedia Patient, an interactive digital platform that provides patients with access to easy-to-understand videos covering a comprehensive range of orthopedic conditions and treatments.

Device Insights

The handheld instruments segment accounted for the largest revenue share in 2024. The handheld instruments segment is growing due to technological developments especially due to adoption of robotics. These minimally invasive surgical instruments are cost effective when compared to other types of minimally invasive surgical instruments. In addition, handheld instruments are easy to operate. All of these aforementioned factors are driving the growth of the segment.

The electrosurgical devices segment is expected to witness strong growth during forecast period. Due to rising frequency of chronic disorders, the ageing population, and the rise in the number of minimally invasive surgical processes, the electrosurgical devices segment is predicted to grow fast throughout the projected period. The demand for cosmetic operations is growing and one key driver driving demand and acceptance of electrosurgical devices in the global market is the rising use of electrosurgical devices in minimally invasive cosmetic surgeries.

Application Insights

The orthopedic segment dominated the market in 2024. The orthopedic minimally invasive surgical processes are quite less risky as compared to traditional surgical methods. As a result, minimally invasive surgical instruments are used in critical orthopedic operations. Due to these factors, minimally invasive surgical instruments are highly adopted by surgeons and orthopedic surgeons.

The cardiac surgery segment is projected to hit strong growth from 2025 to 2034. The minimally invasive operations have a number of advantages over traditional surgeries including less pain and blood loss. In addition, the growing prevalence of cardiovascular disorders is considered as key factor driving the demand for minimally invasive surgical instruments for cardiac surgery.

End Use Insights

The hospital segment accounted revenue share of around 69% in 2024. The market for minimally invasive surgical instruments is expanding due to growing number of hospitals globally. Moreover, the government all around the globe is taking efforts for the development of healthcare facilities. In addition, the rising prevalence of chronic disorders are also contributing towards the growth of the segment.

The ambulatory surgical centers segment is expected to hit remarkable growth during the forecast period. The growing number of ambulatory surgical centers is driving the growth of global minimally invasive surgical instruments market. As per the government records, there are 5,500 ambulatory surgical centers in the U.S. The ambulatory surgical centers are considered as cost effective option as compared to hospitals. The favorable reimbursement policies is driving the adoption of minimally invasive surgical instruments in ambulatory surgical centers on a large scale.

Minimally Invasive Surgical Instruments Market Companies

• The Johns Hopkins Hospital
• Apollo Hospitals Enterprise Ltd.
• The General Hospital Corporation
• Bedfordshire Hospitals
• Stanford Healthcare
• Circle Health Ltd.
• Singapore General Hospital Ltd.
• Manipal Health Enterprises Pvt. Ltd
• Mount Elizabeth Hospital
• King Fahd Medical City 

Latest Announcements by industry Leaders

• In October 2024, LivsMed, a leader in minimally invasive surgical devices announced the release of ArtiSential 5, the first 5mm wristed articulating laparoscopic instrument series on the market. ArtiSential 5 represents a dramatic expansion of the company’s acclaimed ArtiSential line, offering enhanced flexibility and ease of use.

Recent Developments

• In November 2024, IRCAD India, a mirror institute of IRCAD France (Strasbourg), was inaugurated on November 24th in collaboration with Sri Aurobindo Institute of Medical Sciences (SAIMS) in Indore. This marks the establishment of the first Indian centre of excellence solely devoted to training and research & development in the realm of minimally invasive surgery. It adds to the existing Six IRCAD mirror institutes worldwide.
• In April 2024,  MOLLI Surgical unveiled  OncoPen, a minimally invasive surgical tool designed to empower surgeons and improve outcomes for patients affected with breast cancer.This wand is designed to offer surgeons unparalleled directional 3D guidance. Unlike traditional techniques, it eliminates the need for wires, providing increased scheduling flexibility for surgeons and a better patient experience. 

Segments Covered in the Report

By Device

• Handheld Instruments
• Graspers
• Retractors/Elevators
• Suturing Instruments
• Dilators
• Other
• Inflation Devices
• Balloons
• Balloon Inflation Devices
• Surgical Scope
• Laparoscopes
• Urology Endoscopes
• Arthroscopes
• Neuroendoscopes
• Other
• Cutter Instruments
• Trocars
• Other Cutting Instruments
• Guiding Devices
• Guiding Catheters
• Guidewires
• Electrosurgical Devices
• Electrosurgical Instruments
• Electrocautery Device
• Auxiliary Devices
• Monitoring and Visualization Devices

By Application

• Cardiac
• Gastrointestinal
• Orthopedic
• Vascular
• Gynecological
• Urological
• Thoracic
• Cosmetic
• Dental
• Others

By End Use

• Hospitals
• Ambulatory Surgical Centers

 By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa